| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 07/05/2006 | EP1676575A2 Mucin production inhibitor |
| 07/05/2006 | EP1675856A1 Novel tetraydrospiro{piperidine-2,7'-pyrrolo [3,2]pyridine} derivatives and novel indole derivatives useful in the treatment of 5-ht6 receptor -related disorders |
| 07/05/2006 | EP1675852A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 07/05/2006 | EP1675849A1 Benzimidazolyl derivatives |
| 07/05/2006 | EP1675838A1 1-benzoyl substituted diazepine derivatives as selective histamine h3 receptor agonists |
| 07/05/2006 | EP1675836A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
| 07/05/2006 | EP1675835A1 Methods of preparation of dehydro-diketopiperazines in liquid phase or of solid supported phase |
| 07/05/2006 | EP1675826A1 Compounds having crth2 antagonist activity |
| 07/05/2006 | EP1675585A2 Large conductance calcium-activated k channel opener |
| 07/05/2006 | EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/05/2006 | CN1798748A Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 07/05/2006 | CN1798740A Nitrogen-containing heteroaryl derivatives |
| 07/05/2006 | CN1798738A Biaryl substituted pyrazoles as sodium channel blockers |
| 07/05/2006 | CN1798734A Novel compounds and compositions as protein kinase inhibitors |
| 07/05/2006 | CN1798556A Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 07/05/2006 | CN1796385A New method for prepraring Voriconazole intermediate of antifungal drug |
| 07/05/2006 | CN1262547C Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/04/2006 | US7071332 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 07/04/2006 | US7071224 Antihistamines; bronchodilator agents; respiratory system disorders |
| 07/04/2006 | US7071213 Cannabinoid receptor ligands |
| 07/04/2006 | US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 07/04/2006 | US7071201 Serotonin antagonism; muscle relaxant for myotonia; such as 1-(1-(2-(4-methoxyphenyl)ethyl)piperidin-4-yl)-7-methoxy-1,2,3,4 -tetrahydroquinoline |
| 07/04/2006 | US7071196 Piperazine derivatives as antagonists of tachykinins, including substance P and other neurokinins. |
| 07/04/2006 | US7071189 Heterocyclic compounds as antitumor agents with benzimidazole group and morpholine group, triazoline or pyrimidine heterocycles |
| 07/04/2006 | US7071184 Protease inhibitors |
| 07/04/2006 | US7071182 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| 07/04/2006 | US7071180 Eating disorders; cognition activators; psychological disorders; anxiolytic agents; sexual disorders; incontinence; antidepressants |
| 07/04/2006 | CA2332066C Tetrazole compounds as thyroid receptor ligands |
| 07/04/2006 | CA2200579C Phenyl-oxo-alkyl-(4-piperidinyl)benzoate derivatives as colon motility enhancing agents |
| 06/29/2006 | WO2006068991A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/29/2006 | WO2006067976A1 Organic compound, charge-transporting material, and organic electroluminescent element |
| 06/29/2006 | WO2006067529A1 Piperidine and azetidine derivatives as glyt1 inhibitors |
| 06/29/2006 | WO2006067472A1 Parp inhibitors |
| 06/29/2006 | WO2006067466A2 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 06/29/2006 | WO2006067462A1 1,6 - substituted (3r,6r) -3- (2,3-dihydro-1h-inden-2-yl)-2,5-piperazinedione derivatives as oxytocin receptor antagonists for the treatment of pre-term labour, dysmenorrhea and endometriosis |
| 06/29/2006 | WO2006067428A2 1, 2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands |
| 06/29/2006 | WO2006067392A2 Indole derivatives for the treatment of tuberculosis |
| 06/29/2006 | WO2006067391A1 Pyrazolylamino substituted quinazoles for the treatment of cancer |
| 06/29/2006 | WO2006067139A1 Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists |
| 06/29/2006 | WO2006066929A1 Quaternary ammonium salts as m3 antagonists |
| 06/29/2006 | WO2006066928A1 Pyrrolinidium derivatives as m3 muscarinic receptors |
| 06/29/2006 | WO2006066896A2 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 06/29/2006 | WO2006066885A1 Substituted n-heterocyclic compounds and their use as dopamine d3 receptor ligands |
| 06/29/2006 | US20060142579 crystallizing from a solvent selected from 1-propanol, 2-propanol, 1-butanol, ethyl acetate, acetonitrile |
| 06/29/2006 | US20060142578 Novel process |
| 06/29/2006 | US20060142577 4-Diethylamino-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-3-(trifluoromethyl)-benzamide; disease which responds to an inhibition of protein kinase activity, especially a neoplastic disease; leukemia |
| 06/29/2006 | US20060142575 Hetereoaryl nitrile derivatives |
| 06/29/2006 | US20060142572 Inhibitors of ERK protein kinase and uses thereof |
| 06/29/2006 | US20060142571 improved ability to inhibit the replication of mutant strains of drug or multidrug resistant HIV strains; Indene/benzofuran Substituted Pyrimidines |
| 06/29/2006 | US20060142553 Novel azo dye compound |
| 06/29/2006 | US20060142506 Heterobifunctional poly(ethylene glycol) and uses thereof |
| 06/29/2006 | US20060142365 Benzimidazole compounds and antiviral uses thereof |
| 06/29/2006 | US20060142364 2-tert-Butyl-1-(cyclohexylmethyl)-N,N-bis(2,2,2-trifluoroethyl)-1H-benzimidazole-5-carboxamide; treating pain |
| 06/29/2006 | US20060142361 Azole derivatives and methods for making the same |
| 06/29/2006 | US20060142343 Pyrrolines |
| 06/29/2006 | US20060142333 e.g. N-(1-Methyl-1,2,3,4-tetrahydroquinolin-7-yl)-1,1'-biphenyl-4-carboxamide; capsaicin recepor antagonist; analgesic; neuropathic, postoperative, postrheumatoid arthritic, back, cancer pain, neuralgia, dental pain, headache, migraine, diabetic and HIV-related neuropathy |
| 06/29/2006 | US20060142329 Substituted fused N-heteroaryl compounds such as imidazo[1,5a]- or [1,2s]pyridines, e.g., 3-[3-(Pyrrolylphenoxy-2-hydroxypropyl)aminoalkyl]imidazo[1,5-a]pyridine derivatives, especially HCl salts; treating obesity and type 2 diabetes |
| 06/29/2006 | US20060142328 Beta 3 adrenergic agonists |
| 06/29/2006 | US20060142327 Beta 3 adrenergic agonists |
| 06/29/2006 | US20060142325 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 06/29/2006 | US20060142318 eating disorders of disturbed fundus such as dyspepsia, early satiety, bloating, anorexia; fundic relaxation; 1-[1-[(2,3-dihydro[1,4]dioxino[2,3-b]pyridin-3-yl)methyl]-4-piperidinyl]-2-imidazolidinone; improved pharmacokinetics, less vasoconstriction, side effect reduction, sustain release |
| 06/29/2006 | US20060142314 2-substituted-4-(indazol-5-ylamino)-6,7-dimethoxyquinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142313 2-substituted-4-(indazolamino)quinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142307 Controlling intraocular pressure |
| 06/29/2006 | US20060142302 Chemical compounds |
| 06/29/2006 | US20060142301 Substituted 1-benzyl-4-substituted piperazine analogues |
| 06/29/2006 | US20060142300 Anhydrous crystalline forms of I and II of 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1- piperazinyl) 4-oxo-1, 4-dihydroquinoline-3-carboxylic acid (gatifloxacin) |
| 06/29/2006 | US20060142299 Crystalline aripiprazole solvates |
| 06/29/2006 | US20060142293 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis |
| 06/29/2006 | US20060142292 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 06/29/2006 | US20060142281 Indolinone derivatives |
| 06/29/2006 | US20060142264 Novel amide derivatives |
| 06/29/2006 | US20060142263 Such as 5-bromo-thiophene-2-carboxylic acid-{1-[3-chloro-4-(2-oxo-[1,3]oxazinan-3-yl)-phenyl]-5-oxo-pyrrolidin-3-yl}-amide |
| 06/29/2006 | US20060138408 Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof |
| 06/29/2006 | CA2591827A1 1,6 - substituted (3r,6r) -3- (2,3-dihydro-1h-inden-2-yl)-2,5-piperazinedione derivatives as oxytocin receptor antagonists for the treatment of pre-term labour, dysmenorrhea and endometriosis |
| 06/29/2006 | CA2591208A1 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 06/29/2006 | CA2589648A1 Fused pyrazole derivatives and methods of treatment of metabolic-relateddisorders thereof |
| 06/29/2006 | CA2589331A1 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 06/29/2006 | CA2589133A1 Quaternary ammonium salts as m3 antagonists |
| 06/29/2006 | CA2588220A1 Heteroaromatic derivatives useful as anticancer agents |
| 06/29/2006 | CA2588028A1 Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists |
| 06/29/2006 | CA2587664A1 Compounds with kv4 ion channel activity |
| 06/28/2006 | EP1674466A1 2,5- and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors |
| 06/28/2006 | EP1674097A1 Compounds effecting glucokinase |
| 06/28/2006 | EP1673369A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 06/28/2006 | EP1673357A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 06/28/2006 | EP1673355A1 Substituted triazole derivatives as oxytocin antagonists |
| 06/28/2006 | EP1673353A1 Transition state structure and inhibitors of thymidine phosphorylases |
| 06/28/2006 | EP1673350A2 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 06/28/2006 | EP1673348A2 Benzoimidazole compounds |
| 06/28/2006 | EP1673082A2 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases |
| 06/28/2006 | EP1673081A1 Indoles and azaindoles as antiviral agents |
| 06/28/2006 | EP1255536B1 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 06/28/2006 | CN1795193A N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors |
| 06/28/2006 | CN1795188A Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 06/28/2006 | CN1795187A Novel ido inhibitors and methods of use |
| 06/28/2006 | CN1795179A Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 06/28/2006 | CN1795177A 1,2,4-substituerte 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 06/28/2006 | CN1795176A Azabicyclo derivatives as muscarinic receptor antagonists |
| 06/28/2006 | CN1795174A Novel substituted 3-sulfur indoles |